ENDRA Life Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 9, 2023, details the certified results of ENDRA Life Sciences Inc.'s 2023 Annual Meeting of Stockholders. The meeting was held on August 9, 2023, following two previous adjournments on July 6 and July 25 due to a lack of quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Stockholders voted on four proposals with the following outcomes:
- Proposal 1 (Election of Directors): All five nominees were elected. Francois Michelon received the highest support (2,024,988 For), while Louis J. Basenese received the lowest (1,628,081 For). Significant broker non-votes (838,376) were recorded for all candidates.
- Proposal 2 (Say-on-Pay): Stockholders approved the compensation of named executive officers on an advisory basis. Votes were 1,733,406 For, 340,392 Against, and 71,792 Abstain.
- Proposal 3 (Say-on-Pay Frequency): Stockholders recommended an annual advisory vote on executive compensation. Votes were 1,743,563 for One Year, 241,373 for Three Years, and 111,671 for Two Years. The Board determined the vote will occur annually until the next required frequency vote.
- Proposal 4 (Ratification of Auditors): Stockholders ratified the appointment of RBSM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes were 2,794,638 For, 126,032 Against, and 63,296 Abstain.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is strictly a report of the voting results.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the Proxy Statement filed on May 24, 2023, for detailed biographies of the elected directors and executive compensation specifics.
- Confirm the impact of the 838,376 broker non-votes on the quorum and voting thresholds for future meetings.
- Monitor the company's financial status in subsequent filings (10-K or 10-Q) as this 8-K contains no financial data.